A61B2560/029

Passive catheter identification and self-configuration system

In the present invention, a catheter identification system for providing information about one or more attributes of a catheter connectable to an electrophysiology (EP) recording or mapping system includes a catheter, a resistor network operably connected to the catheter, the resistor network including at least one identification resistor and an identification resistor measurement circuit operably connected to the catheter and configured to send an identification signal through the at least one resistor in the resistor network to retrieve an altered identification signal from the identification resistor, where the altered identification signal provides information on an attribute of the catheter.

SYSTEMS AND METHODS TO DETECT CARDIAC EVENTS
20210052229 · 2021-02-25 ·

In some embodiments, features related to inter-beat intervals (IBI) detected by a PPG sensor of a wearable device are extracted and provided to a cardiovascular classifier in order to detect likely instances of a cardiac condition such as atrial fibrillation. Some embodiments use features related to the entropy of the IBI data to improve the predictions generated by the cardiovascular classifier. In some embodiments, co-information between the IBI data and IBI data gathered from healthy and AF populations is determined in order to derive features that represent the probability that a given sample of IBI data represents AF or a normal sinus rhythm. In response to determining likely instances of AF based on these features, the wearable device may obtain clinically acceptable data, such as an ECG, to be transmitted to a separate device for review by a clinician.

SYSTEMS AND METHODS FOR USING CHARACTERISTICS OF PHOTOPLETHYSMOGRAPHY (PPG) DATA TO DETECT CARDIAC CONDITIONS
20210052175 · 2021-02-25 ·

In some embodiments, features are extracted from a waveform generated by a photoplethysmograph (PPG) sensor of a wearable device. These features are used to train and use classifier models to detect likely instances of cardiovascular conditions that affect blood flow during a cardiac cycle, including but not limited to atrial fibrillation. In some embodiments, the features are extracted based on the shape of the waveform, including one or more of an amplitude, an upslope rate, a downslope rate, and differentials thereof over time. In some embodiments, data from an inertial measurement unit (IMU) is used to filter and/or compensate for motion artifacts in the PPG data. The use of data generated by PPG sensors allows long-term, non-invasive monitoring for cardiovascular conditions without requiring further actions to be taken by the user to obtain data using other means.

SYSTEMS AND METHODS FOR LOW POWER PULSE OXIMETRY

Methods and systems are provided for lowering power consumption in an optical sensor, such as a pulse oximeter. In one example, a method for an optical sensor includes illuminating a light emitter of the optical sensor according to set sensor parameters, the sensor parameters set based on hardware noise or external interference characterization and light transmission or reflection of a tissue contributing to a signal output by the optical sensor, the sensor parameters including current drive parameters of the light emitter, and adjusting the current drive parameters of the light emitter to maintain a target signal to noise ratio of the signal output by the optical sensor.

Continuous detection and monitoring of heart arrhythmia using both wearable sensors and cloud-resident analyses

Systems and methods are provided for continuously monitoring a user to determine when cardiovascular events are likely occurring and to responsively provide a prompt to a user to engage in additional physiological assessment of the putative cardiovascular event. Additional assessment can include the user engaging an additional sensor to provide signals that are more accurate, lower noise, or otherwise improved relative to a continuously-monitoring sensor used to initially detect the cardiovascular event. Detection of cardiovascular events includes using a cardiovascular classifier to determine, based on the output of such a continuously-monitoring sensor, whether the event is likely occurring. Such a classifier can be received from a cloud computing service or other remote system based on sensor outputs sent to such a system. Use of such a classifier can facilitate reduced false-positive detection of cardiovascular events based on the continuously-monitoring sensor, and thus reduce extraneous prompts to the user.

Temperature activated vibrating capsule for gastrointestinal treatment, and a method of use thereof
11052018 · 2021-07-06 · ·

A vibrating ingestible capsule includes a housing having a longitudinal axis, and having a vibrating agitator adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule. A power supply disposed within the housing is adapted to power the vibrating agitator. A temperature sensor provides temperature information signals with respect to a temperature in an environment surrounding the vibrating ingestible capsule over a period of time. A control element is adapted to receive the temperature information signals from the temperature sensor, to identify a current temperature-over-time pattern based on the temperature information signals received from said temperature sensor, to compare the current temperature-over-time pattern to a predetermined temperature-over-time pattern, and, after the current temperature-over-time matches the predetermined temperature-over-time pattern, to activate the vibrating agitator to operate in the first vibrating mode of operation.

Method for treating diarrhea and reducing Bristol stool scores using a vibrating ingestible capsule
10888277 · 2021-01-12 · ·

A method for treating diarrhea in a subject and/or for reducing Bristol stool scores of fecal matter of a subject using a vibrating ingestible capsule ingested by the subject and activated in a targeted zone of the gastrointestinal tract of the subject.

Systems and methods for low power pulse oximetry

Methods and systems are provided for lowering power consumption in an optical sensor, such as a pulse oximeter. In one example, a method for an optical sensor includes illuminating a light emitter of the optical sensor according to set sensor parameters, the sensor parameters set based on hardware noise or external interference characterization and light transmission or reflection of a tissue contributing to a signal output by the optical sensor, the sensor parameters including current drive parameters of the light emitter, and adjusting the current drive parameters of the light emitter to maintain a target signal to noise ratio of the signal output by the optical sensor.

Portable complex sensor device for measuring multiple items of biometric information, and measurement method
10849541 · 2020-12-01 · ·

A portable complex sensor device for measuring multiple items of biometric information, according to the present invention, comprises: a plurality of electrodes for receiving the biometric information; a plurality of biometric information measuring circuits for measuring the biometric information received from the plurality of electrodes; a plurality of current sensors which are always supplied with power so as to sense electric current when an object to be measured contacts the electrodes; a wireless communication means for transmitting and receiving data to and from a smart phone; and a microcontroller for controlling the power supply of a battery by being operated in a sleep mode or an active mode on the basis of whether the current sensors have sensed the electric current.

SELECTION OF HYPERTENSIVE PATIENTS FOR TREATMENT WITH RENAL DENERVATION
20200367969 · 2020-11-26 ·

Methods, systems, devices, assemblies and apparatuses for treatment of hypertension in a patient using renal denervation. The therapeutic assembly includes an energy delivery element. The energy delivery element is configured to provide renal denervation energy to a nerve within a blood vessel of a patient. The therapeutic assembly includes a controller. The controller is coupled to the energy delivery element. The controller is configured to determine that the hypertension in the patient is orthostatic. The controller is configured to apply renal denervation energy to the patient using the energy delivery element.